656 related articles for article (PubMed ID: 27565581)
1. The Role of the Gut Microbiome on Chronic Kidney Disease.
Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ
Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581
[TBL] [Abstract][Full Text] [Related]
2. Alterations to the Gut Microbiota and Their Correlation With Inflammatory Factors in Chronic Kidney Disease.
Li F; Wang M; Wang J; Li R; Zhang Y
Front Cell Infect Microbiol; 2019; 9():206. PubMed ID: 31245306
[TBL] [Abstract][Full Text] [Related]
3. Gut microbiome in chronic kidney disease: challenges and opportunities.
Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D
Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis.
Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR
Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574
[TBL] [Abstract][Full Text] [Related]
5. The crosstalk of gut microbiota and chronic kidney disease: role of inflammation, proteinuria, hypertension, and diabetes mellitus.
Kanbay M; Onal EM; Afsar B; Dagel T; Yerlikaya A; Covic A; Vaziri ND
Int Urol Nephrol; 2018 Aug; 50(8):1453-1466. PubMed ID: 29728993
[TBL] [Abstract][Full Text] [Related]
6. Gut Microbiome in Chronic Kidney Disease.
Armani RG; Ramezani A; Yasir A; Sharama S; Canziani MEF; Raj DS
Curr Hypertens Rep; 2017 Apr; 19(4):29. PubMed ID: 28343357
[TBL] [Abstract][Full Text] [Related]
7. Disorder of gut amino acids metabolism during CKD progression is related with gut microbiota dysbiosis and metagenome change.
Liu Y; Li J; Yu J; Wang Y; Lu J; Shang EX; Zhu Z; Guo J; Duan J
J Pharm Biomed Anal; 2018 Feb; 149():425-435. PubMed ID: 29169110
[TBL] [Abstract][Full Text] [Related]
8. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease.
Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E
Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466
[TBL] [Abstract][Full Text] [Related]
9. The clinical impact of gut microbiota in chronic kidney disease.
Kim SM; Song IH
Korean J Intern Med; 2020 Nov; 35(6):1305-1316. PubMed ID: 32872729
[TBL] [Abstract][Full Text] [Related]
10. The role of the gastrointestinal tract and microbiota on uremic toxins and chronic kidney disease development.
Briskey D; Tucker P; Johnson DW; Coombes JS
Clin Exp Nephrol; 2017 Feb; 21(1):7-15. PubMed ID: 26965149
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome in chronic kidney disease.
Wing MR; Patel SS; Ramezani A; Raj DS
Exp Physiol; 2016 Apr; 101(4):471-7. PubMed ID: 26337794
[TBL] [Abstract][Full Text] [Related]
12. Could physical exercise help modulate the gut microbiota in chronic kidney disease?
Esgalhado M; Borges NA; Mafra D
Future Microbiol; 2016 May; 11():699-707. PubMed ID: 27159232
[TBL] [Abstract][Full Text] [Related]
13. [Pathomechanism and treatment of gut microbiota dysbiosis in chronic kidney disease and interventional effects of Chinese herbal medicine].
Han WB; Liu YL; Wan YG; Sun W; Tu Y; Yang JJ; Wu W; He WM; Yao J
Zhongguo Zhong Yao Za Zhi; 2017 Jul; 42(13):2425-2432. PubMed ID: 28840678
[TBL] [Abstract][Full Text] [Related]
14. Microbiota metabolites: Pivotal players of cardiovascular damage in chronic kidney disease.
Cosola C; Rocchetti MT; Cupisti A; Gesualdo L
Pharmacol Res; 2018 Apr; 130():132-142. PubMed ID: 29518493
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in chronic kidney disease.
Cigarran Guldris S; González Parra E; Cases Amenós A
Nefrologia; 2017; 37(1):9-19. PubMed ID: 27553986
[TBL] [Abstract][Full Text] [Related]
16. Diet, gut microbiome and indoxyl sulphate in chronic kidney disease patients.
Yang CY; Tarng DC
Nephrology (Carlton); 2018 Oct; 23 Suppl 4():16-20. PubMed ID: 30298666
[TBL] [Abstract][Full Text] [Related]
17. Microbiome and Cardiovascular Disease in CKD.
Jovanovich A; Isakova T; Stubbs J
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1598-1604. PubMed ID: 29743160
[TBL] [Abstract][Full Text] [Related]
18. The impact of gut microbiota on kidney function and pathogenesis.
Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S
Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798
[TBL] [Abstract][Full Text] [Related]
19. [Uremic toxins and gut micro biome].
Vaziri ND; Suematsu Y; Shimomura A; Vaziri ND
Nihon Jinzo Gakkai Shi; 2017; 59(4):535-544. PubMed ID: 30620802
[TBL] [Abstract][Full Text] [Related]
20. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids.
Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS
Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]